Dr. Edwin Moses will join the Supervisory Board for a term of four years, subject to approval by shareholders at the EGM.
Once approved by the shareholders as a Supervisory Board member, the Supervisory Board will appoint Edwin as the new chair of the Supervisory Board. Kees Verhaar, current chair of the Supervisory Board of Avantium, has decided to step down after the EGM of 20 December 2019.
Avantium is advancing to the next phase of development and commercialization of its technologies. As part of this evolution, Avantium will benefit from Edwin’s proven track record in scaling up innovation and building companies as he has repeatedly demonstrated in an international environment.
He is a highly respected business leader in the life sciences industry with a successful track record in creating company value and attracting both private and public funding in Europe and the United States.
He made substantial contributions at Board level (primarily as Chairman) to over 15 European life sciences companies.
As CEO, Edwin built Ablynx NV and Oxford Asymmetry International, led their successful IPOs on the LSE, Euronext and NASDAQ raising over €500 million in equity and debt financing.
Edwin left Ablynx in 2018, after it had been acquired by Sanofi for €3.9 billion and has focused on helping innovative companies in their value creation process. Currently Edwin is Chairman of biotech companies Achilles Therapeutics (UK), Virion Biotherapeutics (UK and CH) and Evox Therapeutics (UK).
Rob van Leen has notified the company that he will resign as of the end of this year from Avantium’s Supervisory Board for personal reasons. The selection process for a new Supervisory Board member will be started.
Edwin commented on his appointment: “Over the years, I have followed the progress of Avantium. I am impressed by the team, the technologies and the commercial potential of their renewable chemistry solutions. I believe that my experience and expertise can help to bring this innovative company to the next phase of commercialization.”
“Avantium welcomes the Supervisory Board’s decision to nominate Edwin as a new Supervisory Board member. We will greatly benefit from his wealth of experience and expertise. I look forward to our future collaboration in realizing the company’s full potential. I would like to thank Kees for his dedication and guidance in his role of Chairman of Avantium. We wish him every success. I furthermore express my gratitude and appreciation for Rob’s commitment and support to the company.”